Plain-English translation of NCT06980636 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
China
Sponsor
Beijing University of Chinese Medicine
Collaborators
Institute of Chemistry - Vietnam Academy of Science and Technology, Beijing Ditan Hospital
Enrollment target
~100 participants
Started
December 2025
Primary completion
October 2026
Age range
18 Years – 75 Years
Last updated on clinicaltrials.gov in February 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Huijuan Cao, Professor
Beijing University of Chinese Medicine
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.